|Sample:||Urine||Certificate:||ISO, CE, FDA|
|Shelf Life:||24 Months||Read Time:||3 Mins|
Abuse Drug ETG urine test strips,
3 Mins etg urine test strips,
Ethyl Glucuronide ETG Rapid Test Kit
Ethyl Glucuronide ETG Urine Strip Drug of Abuse Rapid Test Kit
Ethyl Glucuronide (ETG) Rapid Test is a rapid, screening test for the qualitative detection of Ethyl Glucuronide (ETG) and metabolites in human urine at specified cut off levels.
For professional use only.
For in vitro diagnostic use only.
【INTENDED USE OF ETG URINE TEST】
Ethyl Glucuronide (ETG) Rapid Test is an immuno-chromatographic assay for the qualitative determination of the presence of Ethyl Glucuronide (ETG). This assay provides only a preliminary analytical test result. Gas Chromatography/Mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to Ethyl Glucuronide (ETG) of abuse test result, particularly when preliminary positive results are indicated.
【SUMMARY OF ETG URINE TEST】
Ethyl Glucuronide (EtG) is a direct metabolite of alcohol. Presence in urine may be used to detect recent alcohol intake, even after alcohol is no longer measurable. Traditional laboratory methods detect the actual alcohol in the body, which reflects current intake within the past few hours (depending on how
much was consumed). The presence of EtG in urine is a definitive indicator that it can be detected in the urine for 3 to 4 days after drinking alcohol, even alcohol
is eliminated from the body. Therefore, EtG is a more accurate indicator of the recent intake of alcohol than measuring for the presence of alcohol itself. The EtG test can aid in the diagnosis of drunk driving and alcoholism, which has important significance in the forensic identification and medical examination
【PRINCIPLE OF ETG URINE TEST】
Ethyl Glucuronide (ETG) Rapid Test is a competitive immunoassay that is used to screen for the presence of Ethyl Glucuronide (ETG) and metabolites in urine. It is chromatographic absorbent device in which, drugs within a urine sample, competitively combined to a limited number of drug monoclonal antibody (mouse) conjugate binding sites.
When the test is activated, the urine is absorbed into test by capillary action, mixes with the respective drug monoclonal antibody conjugate, and flows across a pre-coated membrane. When drug within the urine sample is below the detection level of the test, respective drug monoclonal antibody conjugate binds to the respective drug-protein conjugate immobilized in the Test Region (T) of the test . This produces a colored Test line in the Test Region (T) of the test, which, regardless of its intensity, indicates a negative test result.
When sample drug levels are at or above the detection level of the test, the free drug in the sample binds to the respective drug monoclonal antibody conjugate, preventing the respective drug monoclonal antibody conjugate from binding to the respective drug-protein conjugate immobilized in the Test Region (T) of the device.
This prevents the development of a distinct colored band in the test region, indicating a preliminary positive result.
To serve as a procedure control, a colored line will appear at the Control Region (C) of test, if the test has been performed properly.
Test must be in room temperature (15ºC to 30ºC)
1. Donor collects urine specimen in a urine cup.
2. Open the sealed pouch by tearing along the notch. Remove the test from the pouch and place it on a level surface.
3. Hold the sample dropper vertically, and add exactly three drops of the urine specimen into the sample well.
4. The result should be read at 5 minutes. Do not interpret the result after 10 minutes. See the illustration below.
【INTERPRETATION OF RESULTS】
Positive (+): Only one colored band appears in the control region (C).
Negative (-): Two colored bands appear on the membrane.
Invalid: Control band fails to appear.
【STORAGE AND STABILITY】
What kind of products we also supply?